Alnylam Pharmaceuticals, Inc. ALNY
156.57 USD +4.93 (+3.25%)
Nov 11, 2026, 12:14 PM EST
151.85 Day range 157.15
151.64 52-week range 473.29
- YTD
- -60.63%
- 1 year
- -65.36%
Next earnings
Feb 11, 2027
Expected Feb 11, 2027. Consensus EPS estimate 2.42.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2027 | Dec 30, 2026 | 1.72 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.66 | 16.26 | +14.60 | +879.52% |
| Jul 30, 2026 | Jun 30, 2026 | 1.63 | 1.21 | -0.42 | -25.77% |
| Apr 30, 2026 | Mar 31, 2026 | 0.872 | 1.51 | +0.64 | +73.17% |
| Feb 12, 2026 | Dec 31, 2025 | 1.16 | 0.82 | -0.34 | -29.31% |
| Oct 30, 2025 | Sep 30, 2025 | 0.561 | 1.84 | +1.28 | +227.99% |